L21F (p.Leu21Phe) variant of FBN2 (Fibrillin-2)

L21F (p.Leu21Phe) in FBN2 (Fibrillin-2) is a missense change. Clinical records from EBI and UniProt describe it as benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.30 / 1. The record also includes population frequency data, published literature, and structural context.

L21F (p.Leu21Phe) variant details